HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Elizabeth Arden

This article was originally published in The Rose Sheet

Executive Summary

Fantasy Britney Spears is anticipated to be number one or two women's scent at the department store fragrance bar alongside Calvin Klein Euphoria during the holidays, Elizabeth Arden CEO Scott Beattie reports during JP Morgan Consumer & Retail Holiday Conference Nov. 29 in New York City. Spears' second scent rolled out in September (1"The Rose Sheet" June 27, 2005, p. 5). Singer's first offering, Curious, is "on track" to become the number one women's fragrance at mass, Beattie adds. Exec notes there has been "rapid growth" of prestige fragrances in mass outlets this year, while traditional mass scents have performed "poorly." Commenting on Wal-Mart, Beattie says discount retailer, which currently has a $13 bil. personal care business, likely will become a "destination" for prestige beauty brands...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013543

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel